Literature DB >> 10359340

Naturally occurring vitreous chamber-based myopia in the Labrador retriever.

D O Mutti1, K Zadnik, C J Murphy.   

Abstract

PURPOSE: To investigate whether myopia is present in a breed of domestic dog, the Labrador retriever, and how the ocular components are related to refractive error in this breed.
METHODS: Cycloplegic refractive error was measured in 75 Labrador retrievers by retinoscopy. Corneal and crystalline lens radii of curvature were measured in the right eyes of 57 of these dogs using a video-based keratophakometer, with axial ocular dimensions measured using A-scan ultrasonography.
RESULTS: Of the 75 dogs tested, 11 (14.7%) were myopic by at least -0.50 D in one eye, and 6 (8.0%) were myopic in both eyes (full range of refractive errors, +3.50 D to -5.00 D). Of the 57 dogs with ocular component measurements, seven (12.3%) were myopic by at least -0.50 D in the right eye. There was a significant negative correlation between refractive error and vitreous chamber depth (Spearman r = -0.42; P < 0.001). Myopic eyes had an elongated vitreous chamber depth (10.87+/-0.34 mm for myopic dogs, 10.02+/-0.40 mm for nonmyopic dogs; P < 0.0001, Kruskal-Wallis test). There was also a significant quadratic association between lens thickness and vitreous chamber depth (P < 0.005; R2 = 0. 11), indicating that thinner lenses occurred at both shorter and longer vitreous chamber depths.
CONCLUSIONS: Myopia in the Labrador retriever is analogous to human myopia in that it is caused by an elongated vitreous chamber. Thinner crystalline lenses found at longer vitreous chamber depths may be analogous to lens thinning documented in human ocular development. The Labrador retriever warrants investigation as a potential model of myopia that is naturally occurring rather than experimentally induced.

Entities:  

Mesh:

Year:  1999        PMID: 10359340

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Clinical comparison of the Welch Allyn SureSight™ handheld autorefractor vs. streak retinoscopy in dogs.

Authors:  Allyson D Groth; Steven R Hollingsworth; Ron Ofri; Philip H Kass; Zoe Reed; Christopher J Murphy
Journal:  Vet Ophthalmol       Date:  2012-11-22       Impact factor: 1.644

2.  Species Differences in the Geometry of the Anterior Segment Differentially Affect Anterior Chamber Cell Scoring Systems in Laboratory Animals.

Authors:  Sara M Thomasy; J Seth Eaton; Matthew J Timberlake; Paul E Miller; Steven Matsumoto; Christopher J Murphy
Journal:  J Ocul Pharmacol Ther       Date:  2015-11-05       Impact factor: 2.671

Review 3.  Functional craniology and brain evolution: from paleontology to biomedicine.

Authors:  Emiliano Bruner; José Manuel de la Cuétara; Michael Masters; Hideki Amano; Naomichi Ogihara
Journal:  Front Neuroanat       Date:  2014-04-02       Impact factor: 3.856

4.  Aging Dogs Manifest Myopia as Measured by Autorefractor.

Authors:  Jerome Hernandez; Cecil Moore; Xuemei Si; Stuart Richer; Janet Jackson; Wei Wang
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

5.  The ophthalmic health and refractive state of working dogs in South Brazil.

Authors:  Juliana Kravetz de Oliveira; Mariza Bortolini; Melissa Schaller; Rafaela Kava Schuchmann; Bret A Moore; Fabiano Montiani-Ferreira
Journal:  Open Vet J       Date:  2020-02-11

6.  Naturally-occurring myopia and loss of cone function in a sheep model of achromatopsia.

Authors:  Maya Ross; Ron Ofri; Itzhak Aizenberg; Mazen Abu-Siam; Oren Pe'er; Dikla Arad; Alexander Rosov; Elisha Gootwine; Hay Dvir; Hen Honig; Alexey Obolensky; Edward Averbukh; Eyal Banin; Liat Gantz
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

Review 7.  Characteristics of structures and lesions of the eye in laboratory animals used in toxicity studies.

Authors:  Kazumoto Shibuya; Masayuki Tomohiro; Shoji Sasaki; Seiji Otake
Journal:  J Toxicol Pathol       Date:  2015-07-27       Impact factor: 1.628

8.  Concepts and Strategies in Retinal Gene Therapy.

Authors:  Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-10-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.